PL1828125T3 - Pochodne arylopiperazyny i ich zastosowanie jako liganty selektywne receptora D3 dopaminy - Google Patents

Pochodne arylopiperazyny i ich zastosowanie jako liganty selektywne receptora D3 dopaminy

Info

Publication number
PL1828125T3
PL1828125T3 PL05822892T PL05822892T PL1828125T3 PL 1828125 T3 PL1828125 T3 PL 1828125T3 PL 05822892 T PL05822892 T PL 05822892T PL 05822892 T PL05822892 T PL 05822892T PL 1828125 T3 PL1828125 T3 PL 1828125T3
Authority
PL
Poland
Prior art keywords
nrr
alkylene
polyfluoro
alkyl
dopamine
Prior art date
Application number
PL05822892T
Other languages
English (en)
Inventor
Marc Capet
Denis Danvy
Catherine Dartois
Nicolas Levoin
Marcel Morvan
Isabelle Berrebi-Bertrand
Thierry Calmels
Philippe Robert
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of PL1828125T3 publication Critical patent/PL1828125T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL05822892T 2004-12-01 2005-11-29 Pochodne arylopiperazyny i ich zastosowanie jako liganty selektywne receptora D3 dopaminy PL1828125T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0412763A FR2878524B1 (fr) 2004-12-01 2004-12-01 Nouveaux derives d'arylpiperazine
EP05822892A EP1828125B1 (fr) 2004-12-01 2005-11-29 Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
PCT/FR2005/002964 WO2006058993A1 (fr) 2004-12-01 2005-11-29 Derives d’arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine

Publications (1)

Publication Number Publication Date
PL1828125T3 true PL1828125T3 (pl) 2008-09-30

Family

ID=34951009

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05822892T PL1828125T3 (pl) 2004-12-01 2005-11-29 Pochodne arylopiperazyny i ich zastosowanie jako liganty selektywne receptora D3 dopaminy

Country Status (12)

Country Link
US (1) US20080214542A1 (pl)
EP (1) EP1828125B1 (pl)
AT (1) ATE391711T1 (pl)
DE (1) DE602005006018T2 (pl)
DK (1) DK1828125T3 (pl)
ES (1) ES2302254T3 (pl)
FR (1) FR2878524B1 (pl)
HR (1) HRP20080187T3 (pl)
PL (1) PL1828125T3 (pl)
PT (1) PT1828125E (pl)
SI (1) SI1828125T1 (pl)
WO (1) WO2006058993A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006204522A1 (en) * 2005-01-03 2006-07-13 Universita Degli Studi Di Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
EP2238125A1 (en) * 2008-02-01 2010-10-13 NeuroSearch A/S Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
EP2257531A1 (en) * 2008-03-14 2010-12-08 NeuroSearch A/S Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
EP2354136B1 (en) 2008-10-10 2016-02-24 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China Novel dopamine d3 receptor ligands and preparation and medical uses of the same
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
WO2014079504A1 (en) * 2012-11-22 2014-05-30 Biofordrug S.R.L. Polycyclic ligands of 5-ht7 receptor and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523299A (en) * 1992-08-06 1996-06-04 Smithkline Beecham Plc 5-(2-oxyphenyl)-pyrrole derivatives as dopamine D3 receptor antagonists
US5523229A (en) * 1994-03-22 1996-06-04 Trustees Of The University Of Pennsylvania Antibodies specific for oncofetal fibronectin
WO2001049679A1 (en) * 1999-12-30 2001-07-12 H. Lundbeck A/S 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
EP1474399A1 (en) * 2002-02-13 2004-11-10 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
US20040204422A1 (en) * 2003-04-14 2004-10-14 Abbott Gmbh & Co. Kg. N-[(Piperazinyl)hetaryl]arylsulfonamide compounds

Also Published As

Publication number Publication date
WO2006058993A1 (fr) 2006-06-08
DE602005006018D1 (de) 2008-05-21
DE602005006018T2 (de) 2008-07-10
FR2878524B1 (fr) 2007-01-19
EP1828125A1 (fr) 2007-09-05
EP1828125B1 (fr) 2008-04-09
DK1828125T3 (da) 2008-08-04
ATE391711T1 (de) 2008-04-15
US20080214542A1 (en) 2008-09-04
SI1828125T1 (sl) 2008-08-31
ES2302254T3 (es) 2008-07-01
PT1828125E (pt) 2008-08-22
FR2878524A1 (fr) 2006-06-02
HRP20080187T3 (en) 2008-05-31

Similar Documents

Publication Publication Date Title
HRP20080187T3 (en) Arylpiperazine derivatives and their use as ligangs selective of the dopamine d3 receptor
TNSN05328A1 (en) (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
RS52245B (en) CYTOTOXIC AGENTS CONTAINING NEW TOMAIMYCIN DERIVATIVES AND THEIR THErapeutic Use
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
NZ525700A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
NO20076418L (no) Heterocyclic compounds as agonists for the thyroid receptor
RS53627B1 (en) N- (3-Amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
AR056321A1 (es) COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
MY148988A (en) Terphenyl derivatives for treatment of alzheimer's disease
HK1146049A1 (en) Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
IL183061A0 (en) Aryloxyethylamine derivatives with a combination of partial dopamine d2 receptor agonism and serotonin reuptake inhibition
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
AR048948A1 (es) Una composicion farmaceutica antimicobacteriana
PE20060868A1 (es) Sales de aminio de 1,2,3- triazoles como profarmacos que incluyen agentes antivirales
PE20090320A1 (es) Derivados de piperidina-amida
DK1659112T3 (da) Arylpiperazinderivater som selektiv ligand for dopamin D3 receptor
TW200634008A (en) Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
MX2010007967A (es) N-[3-bromo-2-cloro-4-(4,5-dihidro-1h-imidazol-2-ilmetil)-fenil]-m etansulfoamida como agonista parcial alfa-1 a adrenergico para el tratamiento de la incontinencia.
WO2009069680A1 (ja) 消化管間質腫瘍（ｇｉｓｔ）を処置するための医薬組成物、ならびに消化管間質腫瘍を患う患者の予後を予測するためのキットおよび方法
TW200637553A (en) Indlomorphinane derivatives having a carboxy group at 6' position
TH102702B (th) กระบวนการสำหรับการเตรียม 2-(2,6-ไดออกโซพิเพอริดิน-3-อิล)-1-ออกโซไอโซอินโดไลน์ถูกแทนที่
HUP0500461A2 (en) Pyperazine derivatives of alkyl-oxindoles